期刊文献+

LRIG1基因过表达载体的构建、鉴定及在食管鳞癌细胞株Eca109中的表达

Construction,identification of LRIG1 over-expression vector and expression in esophageal cancer strain Eca109
原文传递
导出
摘要 目的构建LRIG1基因过表达载体,并进行鉴定。方法采用PCR方法从食管癌的LRIG1c DNA表达阳性的标本中扩增出LRIG1基因,经用Xho I和Kpn I-HF双酶切后,与过表达载体GV219相连后转入E.coli DH5α。结果 DNA测序证明获得了包含ORF全长的LRIG1基因,并成功克隆入过表达载体GV219中。经转染Eca109细胞株后,应用蛋白免疫荧光技术检测过表达的LRIG1。结论构建过表达载体成功,为进一步探讨LRIG1基因在食管癌中的作用奠定了基础。 [Objective]To construct and identify a lentiviral vector for over-expression of LRIG1 gene.[Methods]PCR was used to clone LRIG1 gene with esophageal cancer c DNA as a template.After digesting with endonuclease enzyme Eco RI and Kpn I-HF,LRIG1 gene was linked with eukaryotic expression vector GV219 and transferred into E.coli DH5α.[Results]DNA sequence which included ORF was obtained,and which was successfully linked with eukaryotic expression vector GV219.After transfection with Eca109 strain,over-expression LRIG1 gene was detected by protein immunofluorescence technique.[Conclusion]The lentiviral vector over-expressing LRIG1 gene is successfully constructed,which lays the foundation for further study of the role of LRIG1 gene in esophageal cancer.
作者 吉别克.瓦提别克 李惠武 喻亮 路晨菲 范志勤 李颖 李卉 刘玲 JIBIEKE·Watibieke;LI Hui-wu;YU Lian;LU Chen-fei;FAN Zhi-qin;LI Ying;LI Hui;LIU Ling(Preclinical College;Affiliated Tumor Hospital;Public Healthy College;Clinical Medical College;Central Laboratory, Xinjiang Medical University, Urumqi Xinjiang, 830011, China)
出处 《职业与健康》 CAS 2018年第5期611-616,共6页 Occupation and Health
基金 国家自然科学基金项目(81460419) 新疆维吾尔自治区大学生创新性实验计划项目(201610760055) 新疆医科大学大学生创新性实验计划项目(CX2016055)
关键词 LRIG1表达载体 构建 鉴定 LRIG1 expression vector Construction Identification
  • 相关文献

参考文献4

二级参考文献37

  • 1叶飞,郭东升,牛洪泉,陶胜中,欧一博,卢运萍,雷霆.LRIG1cDNA诱导人胶质瘤细胞系H4凋亡的分子机制[J].癌症,2004,23(10):1149-1154. 被引量:19
  • 2叶章群,严泽军,杨为民,郭东升.LRIG1基因对膀胱癌细胞侵袭力的影响[J].中华外科杂志,2007,45(4):258-261. 被引量:13
  • 3Ledda F, Bieraugel O, Fard SS, et al. Lrigl is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF[J]. J Neurosci, 2008, 28(1): 39-49. 被引量:1
  • 4Yi W, Haapasalo H, Holmlund C, et al. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age[J]. Clin Neuropathol, 2009, 28(1): 21-27. 被引量:1
  • 5Ye F, Gao Q, Cai MJ. Therapeutic targeting of EGFR in malignant gliomas[J]. Expert Opin Ther Targets, 2010, 14(3): 303-316. 被引量:1
  • 6Ehmann LM, Heinemann V, Wollenberg A. New tyrosine kinase and EGFR inhibitors in cancer therapy. Cardiac and skin toxicity as relevant side effects. Part B: Skin[J]. Internist (Berl), 2011, 52(11): 1359-1364. 被引量:1
  • 7Thomasson M, Wang B, Hammarsten P, et al. LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer[J]. Int J Cancer, 2011,128 (12): 2843-2852. 被引量:1
  • 8Ghasimi S, Haapasalo H, Eray M, et al. lmmunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression [J]. J Neurooncol, 2012, 108(3): 435-441. 被引量:1
  • 9Rouam T, Moreau S, Broet P. Identifying common prognostic factors in genomic cancer studies: a novel index for censored outcomes[J]. BMC Bioinformatics, 2010, 11: 150. 被引量:1
  • 10Segatto S, Anastasi O, Alema S. Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors[J]. J Cell Sci, 2011, 124(Pt 11): 1785-1793. 被引量:1

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部